Paper39149351
Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners.
Coate KC and 19 others. bioRxiv, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners. Papers, record 39149351. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39149351
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants14
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UC4 DK104218 | NIDDK NIH HHS | United States | U01DK104218 | PubMed and NIH | NIH RePORTER |
| UC4 DK104211 | NIDDK NIH HHS | United States | UC4DK104211 | PubMed and NIH | NIH RePORTER |
| P30 DK058404 | NIDDK NIH HHS | United States | P30DK058404 | PubMed and NIH | NIH RePORTER |
| F31 DK134158 | NIDDK NIH HHS | United States | F31DK134158 | PubMed and NIH | NIH RePORTER |
| UC4 DK112232 | NIDDK NIH HHS | United States | UC4DK112232 | PubMed and NIH | NIH RePORTER |
| U01 DK104218 | NIDDK NIH HHS | United States | U01DK104218 | PubMed and NIH | NIH RePORTER |
| R01 DK117147 | NIDDK NIH HHS | United States | R01DK117147 | PubMed and NIH | NIH RePORTER |
| R01 DK132669 | NIDDK NIH HHS | United States | R01DK132669 | PubMed and NIH | NIH RePORTER |
| T35 DK007383 | NIDDK NIH HHS | United States | T35DK007383 | PubMed and NIH | NIH RePORTER |
| I01 BX000666 | BLRD VA | United States | I01BX000666 | PubMed and NIH | NIH RePORTER |
| P30 DK020593 | NIDDK NIH HHS | United States | P30DK020593 | PubMed and NIH | NIH RePORTER |
| R24 DK106755 | NIDDK NIH HHS | United States | R24DK106755 | PubMed and NIH | NIH RePORTER |
| K01 DK117969 | NIDDK NIH HHS | United States | K01DK117969 | PubMed and NIH | NIH RePORTER |
| UC4DK104218 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Updated in | 39433176 | Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners. | https://conductscience.org/library/papers/39433176 |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35649369 | Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy. | Cell Rep | 2022 | https://conductscience.org/library/papers/35649369 | PubMed |
| 2 | 31424428 | β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31424428 | PubMed |
| 3 | 26020795 | Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys. | Endocrinology | 2015 | https://conductscience.org/library/papers/26020795 | PubMed |
| 4 | 31653720 | A Primary Role for α-Cells as Amino Acid Sensors. | Diabetes | 2020 | https://conductscience.org/library/papers/31653720 | PubMed |
| 5 | 11549624 | Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. | J Clin Endocrinol Metab | 2001 | https://conductscience.org/library/papers/11549624 | PubMed |
| 6 | 36826938 | Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice. | Diabetes | 2023 | https://conductscience.org/library/papers/36826938 | PubMed |
| 7 | 35784565 | Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35784565 | PubMed |
| 8 | 19129372 | Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys. | J Pharmacol Exp Ther | 2009 | https://conductscience.org/library/papers/19129372 | PubMed |
| 9 | 12552113 | Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12552113 | PubMed |
| 10 | 4912452 | Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. | N Engl J Med | 1970 | https://conductscience.org/library/papers/4912452 | PubMed |
| 11 | 16627579 | Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. | Endocrinology | 2006 | https://conductscience.org/library/papers/16627579 | PubMed |
| 12 | 42294887 | Pancreatic islet α cell function and proliferation require the arginine transporter SLC7A2. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42294887 | PubMed |
| 13 | 11278602 | Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11278602 | PubMed |
| 14 | 17326133 | Conditional targeted cell ablation in zebrafish: a new tool for regeneration studies. | Dev Dyn | 2007 | https://conductscience.org/library/papers/17326133 | PubMed |
| 15 | 36450253 | Glycemic control releases regenerative potential of pancreatic beta cells blocked by severe hyperglycemia. | Cell Rep | 2022 | https://conductscience.org/library/papers/36450253 | PubMed |
| 16 | 31203188 | Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice. | iScience | 2019 | https://conductscience.org/library/papers/31203188 | PubMed |
| 17 | 31127054 | NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP). | Diabetes | 2019 | https://conductscience.org/library/papers/31127054 | PubMed |
| 18 | 25852199 | Glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis. | Development | 2015 | https://conductscience.org/library/papers/25852199 | PubMed |
| 19 | 30929915 | Glucagon receptor antagonism increases mouse pancreatic δ-cell mass through cell proliferation and duct-derived neogenesis. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/30929915 | PubMed |
| 20 | 36206763 | Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program. | Cell Metab | 2022 | https://conductscience.org/library/papers/36206763 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| GCGR | 2642 | PubTator's text mining | https://conductscience.org/library/genes/2642 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39149351
GET https://conductscience.org/api/papers/v1/39149351/references?page=2